A Case Report on Two-Month-Old-Infant Atypical Kawasaki Disease

Atypical Kawasaki Disease in Infant

Authors

  • . Razia Shifa College of Nursing, Shifa Tameer-e-Millat University, Islamabad, Pakistan
  • Shafaat Ullah Shifa College of Nursing, Shifa Tameer-e-Millat University, Islamabad, Pakistan
  • Kainat Asmat Shifa College of Nursing, Shifa Tameer-e-Millat University, Islamabad, Pakistan
  • Mohammad Saleem Shifa College of Nursing, Shifa Tameer-e-Millat University, Islamabad, Pakistan
  • Ihsan Ur Rehman Shifa College of Nursing, Shifa Tameer-e-Millat University, Islamabad, Pakistan
  • . Jahanzeb Khyber Medical University, Peshawar, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v6i4.2699

Keywords:

Atypical Kawasaki Disease, Infant Presentation, Coronary Complications, Early Diagnosis

Abstract

Kawasaki Disease (KD) is a rare vasculitis that predominantly affects children under five, with atypical presentations posing significant diagnostic challenges, especially in infants. This case report describes a two-month-old male who initially presented with high-grade fever and rash, misdiagnosed as subclinical meningitis. Despite multiple hospitalizations and extensive investigations, a definitive diagnosis was delayed. The patient later developed seizures, respiratory distress, and shock, necessitating intensive care. Laboratory findings revealed elevated inflammatory markers, anemia, thrombocytosis, and abnormal echocardiographic findings. Whole-body CT and detailed ECHO ultimately confirmed atypical KD with multiple thromboses and giant coronary aneurysms. Prompt treatment with intravenous immunoglobulin (IVIG), corticosteroids, anticoagulants, and antiplatelet agents was initiated. Although the patient improved clinically, irreversible cardiovascular complications had developed. This case highlights the importance of maintaining a high index of suspicion for atypical KD in febrile infants lacking classic symptoms. Early diagnosis and timely initiation of IVIG are essential to prevent long-term cardiac sequelae. Enhanced clinical awareness and refined diagnostic protocols are critical for improving outcomes in such vulnerable pediatric populations.

References

Jone PN, Tremoulet A, Choueiter N, Dominguez SR, Harahsheh AS, Mitani Y et al. Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association. Circulation. 2024 Dec; 150(23): e481-500. doi: 10.1161/CIR.0000000000001295.

Owens AM. Kawasaki Disease [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited on: 15th Apr 2025]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537163.

Tutic E and Evey K. Kawasaki Disease: Recent Diagnostics, Treatment, and Predictors for Treatment Failure and Coronary Artery Involvement. Current Emergency and Hospital Medicine Reports. 2023 Dec; 11(4): 158-64. Doi: 10.1007/s40138-023-00273-4.

Jain B, Agarwal H, Bhatia N, Yadav V. Atypical Kawasaki Disease. Max Med J. 2024 Mar; 1(1): 102-4. doi: 10.62830/MMJ1-4-17C.

Scherler L, Haas NA, Tengler A, Pattathu J, Mandilaras G, Jakob A. Acute phase of Kawasaki disease: a review of national guideline recommendations. European Journal of Pediatrics. 2022 Jul; 181(7): 2563-73. doi: 10.1007/s00431-022-04458-z.

Kuo HC. Diagnosis, progress, and treatment update of Kawasaki disease. International Journal of Molecular Sciences. 2023 Sep; 24(18): 13948. doi: 10.3390/ijms241813948.

Navidi N, Najibi B, Dinarvand N, Zamani A, Fathi MR. Atypical Kawasaki disease with giant coronary artery aneurysms in a 2-month-old boy: a case report. Journal of Medical Case Reports. 2024 Dec; 18(1): 630. doi: 10.1186/s13256-024-04987-1.

Raza AA, Khan W, Khan AA, Mahrukh SK, Balasubramanian K. Atypical Kawasaki Disease Presentation in a Previously Healthy Infant: A Diagnostic Challenge. Cureus. 2023 Oct; 15(10). doi: 10.7759/cureus.46748.

Tsujioka Y, Handa A, Nishimura G, Miura M, Yokoyama K, Sato K et al. Multisystem imaging manifestations of Kawasaki disease. Radiographics. 2022 Jan; 42(1): 268-88. doi: 10.1148/rg.210070.

Garrido-García LM, Gutiérrez-Alanis JH, Ramírez-Perea AI, Tremoulet A, Yamazaki-Nakashimada MA. Kawasaki disease in infants in the first 3 months of age in a Mexican population: a cautionary tale. Frontiers in Pediatrics. 2020 Jul; 8: 397. doi: 10.3389/fped.2020.00397.

Marzano AV, Cassano N, Moltrasio C, Verdoni L, Genovese G, Vena GA. Multisystem inflammatory syndrome in children associated with COVID-19: a review with an emphasis on mucocutaneous and kawasaki disease-like findings. Dermatology. 2022 Jun; 238(1): 35-43. doi: 10.1159/000515449.

Lee JJ, Lin E, Widdifield J, Mahood Q, McCrindle BW, Yeung RS et al. The long-term cardiac and noncardiac prognosis of Kawasaki disease: a systematic review. Pediatrics. 2022 Mar; 149(3): e2021052567. doi: 10.1542/peds.2021-052567.

Yi XX, Zhang WR, Wang DM, Wang XP, Zhang FX. Research perspective in the clinical management of Kawasaki disease. Frontiers in Pediatrics. 2024 Jul; 12: 1415941. doi: 10.3389/fped.2024.1415941.

Li C, Zhang H, Yin W, Zhang Y. Development and validation of a nomogram-based prognostic model to predict coronary artery lesions in Kawasaki disease from 6847 children in China. Computer Methods and Programs in Biomedicine. 2025 Mar; 260: 108588. doi: 10.1016/j.cmpb.2024.108588.

Burns JC, Roberts SC, Tremoulet AH, et al. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. The Lancet Child & Adolescent Health. 2021 Dec; 5(12): 852–861. doi: 10.1016/S2352-4642(21)00270-4.

He L, Liu F, Yan W, et al. Randomized trial of different initial intravenous immunoglobulin regimens in Kawasaki disease. Pediatric International. 2021 Jul; 63(7): 757–763. doi: 10.1111/ped.14656.

Ogata S, Ogihara Y, Honda T, et al. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial. Pediatrics. 2012 Jan; 129(1): e17–e23. doi: 10.1542/peds.2011-0148.

Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006 Jun; 113(22): 2606–2612. doi: 10.1161/CIRCULATIONAHA.105.592865.

McCrindle BW, Li JS, Minich LL, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007 Jul; 116(2): 174–179. doi: 10.1161/CIRCULATIONAHA.107.690875.

Kuo HC, Lo MH, Hsieh KS, et al. Single-nucleotide polymorphism rs7251246 in ITPKC is associated with susceptibility and coronary artery lesions in Kawasaki disease. PLOS One. 2014 Mar; 9(4): e91118. doi: 10.1371/journal.pone.0091118.

Downloads

Published

2025-04-30
CITATION
DOI: 10.54393/pjhs.v6i4.2699
Published: 2025-04-30

How to Cite

Razia, ., Ullah, S., Asmat, K., Saleem, M., Rehman, I. U., & Jahanzeb, . (2025). A Case Report on Two-Month-Old-Infant Atypical Kawasaki Disease: Atypical Kawasaki Disease in Infant. Pakistan Journal of Health Sciences, 6(4). https://doi.org/10.54393/pjhs.v6i4.2699

Issue

Section

Case Report

Plaudit